Luliconazole
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Luliconazole is a azole antifungal that is FDA approved for the treatment of interdigital tinea pedis, tinea cruris, and tinea corporis. Common adverse reactions include application site reactions.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older.
Dosage
For topical use only. LUZU Cream, 1% is not for ophthalmic, oral, or intravaginal use.
When treating interdigital tinea pedis, a thin layer of LUZU Cream, 1% should be applied to the affected area and approximately 1 inch of the immediate surrounding area(s) once daily for two (2) weeks. When treating tinea cruris or tinea corporis, LUZU Cream, 1% should be applied to the affected area and approximately 1 inch of the immediate surrounding area(s) once daily for one (1) week.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Luliconazole in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Luliconazole in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
- safety and efficacy not established in pediatric patients
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Luliconazole in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Luliconazole in pediatric patients.
Contraindications
- Condition1
Warnings
- Description
Precautions
- Description
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Luliconazole in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Luliconazole in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Drug Interactions
- Drug
- Description
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Luliconazole in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Luliconazole during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Luliconazole with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Luliconazole with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Luliconazole with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Luliconazole with respect to specific gender populations.
Race
There is no FDA guidance on the use of Luliconazole with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Luliconazole in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Luliconazole in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Luliconazole in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Luliconazole in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
- Intravenous
Monitoring
There is limited information regarding Monitoring of Luliconazole in the drug label.
- Description
IV Compatibility
There is limited information regarding IV Compatibility of Luliconazole in the drug label.
Overdosage
Acute Overdose
Signs and Symptoms
- Description
Management
- Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Luliconazole in the drug label.
Pharmacology
There is limited information regarding Luliconazole Pharmacology in the drug label.
Mechanism of Action
Structure
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Luliconazole in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Luliconazole in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Luliconazole in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Luliconazole in the drug label.
How Supplied
Storage
There is limited information regarding Luliconazole Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Luliconazole |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Luliconazole |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Luliconazole in the drug label.
Precautions with Alcohol
- Alcohol-Luliconazole interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ®[1]
Look-Alike Drug Names
- A® — B®[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ Empty citation (help)
- ↑ "http://www.ismp.org". External link in
|title=
(help)
{{#subobject:
|Page Name=Luliconazole |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Luliconazole |Label Name=Luliconazole11.png
}}
{{#subobject:
|Label Page=Luliconazole |Label Name=Luliconazole11.png
}}